Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Change in Acquisitions & Divestments (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Change in Acquisitions & Divestments for 2 consecutive years, with $21.0 million as the latest value for Q4 2023.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 73.83% to $21.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $22.5 million, a 86.78% decrease, with the full-year FY2024 number at $87.9 million, up 290.67% from a year prior.
  • Change in Acquisitions & Divestments was $21.0 million for Q4 2023 at LENZ Therapeutics, up from $1.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $90.0 million in Q3 2022 to a low of $1.5 million in Q3 2023.